Danyan Xu

central south university

H指数:25

被引数:2,355

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis reply

ECLINICALMEDICINE

IF10

2026-01-010

OAAI

Aerobic exercise alleviates statin-induced PCSK9 upregulation by increasing epoxyeicosatrienoic acid levels through the FoxO3a-Sirt6 axis

有氧运动通过FoxO3a-Sirt6轴增加环氧二十碳三烯酸水平，从而缓解他汀诱导的PCSK9上调。

JOURNAL OF SPORT AND HEALTH SCIENCE

IF10.3

2025-02-281

OAAI

Sex differences in the relationship between olfactory and cognitive impairment among subjects with subjective cognitive decline and mild cognitive impairment

主观认知减退和轻度认知损害者嗅觉与认知损害关系的性别差异

BIOLOGY OF SEX DIFFERENCES

IF5.1

2025-02-130

OAAI

Mechanism of empagliflozin improves aortic pathological remodeling in TAAD mice based on NLRP3 inflammasome

基于NLRP3炎症小体的恩格列净改善TAAD小鼠主动脉病理性重塑的机制

CIRCULATION

IF38.6

2024-11-120

PRE

Effects of different exercise methods and intensities on the incidence and prognosis of atrial fibrillation

TRENDS IN CARDIOVASCULAR MEDICINE

IF9

2024-11-014

OAAI

Real world experience in effect of torsemide vs. furosemide after discharge in patients with HFpEF

ESC HEART FAILURE

IF3.7

2024-09-050

OAAI

Altered resting-state brain oscillation and the associated cognitive impairments in late-life depression with different depressive severity: An EEG power spectrum and functional connectivity study

不同抑郁严重程度的晚年抑郁症患者静息态脑振荡改变及相关认知障碍: 脑电图功率谱和功能连接研究

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2024-03-013

PRE

Research progress on the role and mechanism of GDF15 in body weight regulation

GDF15在体重调节中的作用及机制研究进展

OBESITY FACTS

IF4.7

2023-11-2110

OAAI

Complex Interplay Between Metabolism and CD4+ T-Cell Activation, Differentiation, and Function: a Novel Perspective for Atherosclerosis Immunotherapy

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2023-05-188

PRE

Regulatory T Cells in Pathological Cardiac Hypertrophy: Mechanisms and Therapeutic Potential

病理性心脏肥大中的调节性T细胞: 机制和治疗潜力

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2023-05-153

PRE

Arterial remodeling: the role of mitochondrial metabolism in vascular smooth muscle cells

动脉重塑: 线粒体代谢在血管平滑肌细胞中的作用

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

IF4.7

2023-01-0120

PRE

Direct Oral Anticoagulants Combined with Antiplatelet Therapy in the Treatment of Coronary Heart Disease: An Updated Meta-analysis

DRUGS

IF14.4

2021-11-033

PREAI

The roles of T cells in obese adipose tissue inflammation

T细胞在肥胖脂肪组织炎症中的作用

ADIPOCYTE

IF3.1

2021-09-1332

OAAI

The Effect of Enhanced External Counterpulsation on Platelet Aggregation in Patients with Coronary Heart Disease (Jan, 10.1007/s10557-020-07140-4, 2021)

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2021-02-050

OAAI

The Effect of Enhanced External Counterpulsation on Platelet Aggregation in Patients with Coronary Heart Disease

增强型体外反搏对冠心病患者血小板聚集的影响

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2021-01-212

PREAI

The role and research progress of the balance and interaction between regulatory T cells and other immune cells in obesity with insulin resistance

ADIPOCYTE

IF3.1

2021-01-2014

OAAI

Optimal fermentation time for Nigrospora-fermented tea rich in bostrycin

JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE

IF3.5

2020-11-1010

PREAI

Sex differences in survival after out-of-hospital cardiac arrest: a meta-analysis

院外心脏骤停后生存率的性别差异: 一项荟萃分析

CRITICAL CARE

IF9.3

2020-10-1953

OAAI

Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the Prime Time of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2020-06-0420

PREAI

Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction

无机硝酸盐与安慰剂治疗保留射血分数的心力衰竭的疗效和安全性

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2020-05-115

PREAI

Danyan Xu

个人简介

教育背景

工作经历

荣誉奖项

研究方向